MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of marketable...
$46,465K
Proceeds from sale of
common stock received...
$20,000K
Proceeds from the
issuance of common stock...
$16K
Net cash provided by
investing activities
$47,268K
Net cash provided by
financing activities
$16K
Canceled cashflow
$19,197K
Net increase
(decrease) in cash and cash...
$17,471K
Canceled cashflow
$29,813K
Purchases of marketable
securities
$17,697K
Investment in joint venture
$1,500K
Share-based compensation
$5,314K
Loss on investment in
joint venture
-$874K
Depreciation and
amortization
$92K
Net cash used in
operating activities
-$29,813K
Canceled cashflow
$6,280K
Gain on sale of joint
venture
$22,350K
Net loss
-$8,978K
Prepaid expenses,
operating right-of-use...
$2,043K
Accrued expenses and
operating lease...
-$1,149K
Deferred revenue
-$848K
Net accretion of
discounts/premiums on debt...
-$573K
Accounts payable
-$152K
Back
Back
Cash Flow
source: myfinsight.com
Rallybio Corp (RLYB)
Rallybio Corp (RLYB)